CL2016001486A1 - Uso de un suero dulce de leche modificado y una fórmula para bebés que contiene suero dulce de leche modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas. - Google Patents

Uso de un suero dulce de leche modificado y una fórmula para bebés que contiene suero dulce de leche modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas.

Info

Publication number
CL2016001486A1
CL2016001486A1 CL2016001486A CL2016001486A CL2016001486A1 CL 2016001486 A1 CL2016001486 A1 CL 2016001486A1 CL 2016001486 A CL2016001486 A CL 2016001486A CL 2016001486 A CL2016001486 A CL 2016001486A CL 2016001486 A1 CL2016001486 A1 CL 2016001486A1
Authority
CL
Chile
Prior art keywords
sweet whey
modified sweet
children
promote
nervous system
Prior art date
Application number
CL2016001486A
Other languages
English (en)
Inventor
Magali Faure
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49759173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001486(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2016001486A1 publication Critical patent/CL2016001486A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pediatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL2016001486A 2013-12-13 2016-06-13 Uso de un suero dulce de leche modificado y una fórmula para bebés que contiene suero dulce de leche modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas. CL2016001486A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13197205 2013-12-13

Publications (1)

Publication Number Publication Date
CL2016001486A1 true CL2016001486A1 (es) 2017-01-20

Family

ID=49759173

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001486A CL2016001486A1 (es) 2013-12-13 2016-06-13 Uso de un suero dulce de leche modificado y una fórmula para bebés que contiene suero dulce de leche modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas.

Country Status (9)

Country Link
US (1) US10517918B2 (es)
EP (1) EP3079485B2 (es)
CN (1) CN105979796A (es)
AU (2) AU2014363470B2 (es)
CL (1) CL2016001486A1 (es)
MX (1) MX2016007630A (es)
PH (1) PH12016500732A1 (es)
RU (1) RU2692488C1 (es)
WO (1) WO2015086789A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL235821B1 (pl) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
JP2018525390A (ja) * 2015-08-31 2018-09-06 ネステク ソシエテ アノニム 抑うつ症状を治療又は予防するための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
US11918006B2 (en) 2016-05-12 2024-03-05 Arla Foods Amba Whey preparation for improving brain development
SG11201809593YA (en) * 2016-07-01 2018-11-29 Nestec Sa Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
JP6435079B1 (ja) * 2017-03-10 2018-12-05 株式会社明治 体内ｂｄｎｆ量増加促進用組成物
JP2018184369A (ja) * 2017-04-26 2018-11-22 株式会社明治 知的作業能力向上用組成物および認知能力向上用組成物
WO2019027974A1 (en) * 2017-07-31 2019-02-07 Immunotec Inc. Compositions and methods for treatment of autism spectrum disorder
US20210244777A1 (en) * 2017-12-08 2021-08-12 Morinaga Milk Industry Co., Ltd. Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
JP7436358B2 (ja) * 2018-03-23 2024-02-21 森永乳業株式会社 母乳成分増強用組成物
WO2020001863A1 (en) * 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
WO2020001862A1 (en) * 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
CN110664848A (zh) * 2019-11-19 2020-01-10 江南大学 CCFM1025在制备缓解自闭症和吸附PCBs的食品或药物中的应用
JP2021171059A (ja) * 2020-04-21 2021-11-01 サンスター株式会社 遂行機能改善用組成物
CN114533766B (zh) * 2022-03-17 2023-08-25 江南大学 长双歧杆菌婴儿亚种ccfm687在调节神经细胞髓鞘化中的应用
US12349701B2 (en) 2023-01-13 2025-07-08 Leprino Foods Company Denatured milk proteins, methods of making, and protein fortified foods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0880902A1 (fr) * 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
CA2371696C (en) 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
AR026771A1 (es) * 1999-12-08 2003-02-26 New Zealand Co Operartive Dair Metodo para obtener un producto con cantidad reducida de glucomacropeptidos, a partir de suero
ATE433674T1 (de) 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
EP1638415B1 (en) * 2003-06-23 2010-12-15 Nestec S.A. Infant or follow-on formula
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP2251031A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
NO333013B1 (no) 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
CN101773223B (zh) 2010-02-11 2013-01-02 圣元营养食品有限公司 婴儿食品组合物
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2013138157A1 (en) * 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids

Also Published As

Publication number Publication date
EP3079485A1 (en) 2016-10-19
RU2692488C1 (ru) 2019-06-25
EP3079485B2 (en) 2022-03-30
AU2018211313A1 (en) 2018-08-23
AU2014363470B2 (en) 2018-09-06
US20160310557A1 (en) 2016-10-27
MX2016007630A (es) 2016-09-09
CN105979796A (zh) 2016-09-28
WO2015086789A1 (en) 2015-06-18
AU2014363470A1 (en) 2016-04-14
EP3079485B1 (en) 2019-05-01
PH12016500732A1 (en) 2016-05-30
US10517918B2 (en) 2019-12-31

Similar Documents

Publication Publication Date Title
CL2016001486A1 (es) Uso de un suero dulce de leche modificado y una fórmula para bebés que contiene suero dulce de leche modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas.
HUE039997T2 (hu) Szulfamoilpirrolamid származékok és alkalmazásuk hepatitisz B kezelésére szolgáló gyógyszerekként
HUE040446T2 (hu) Szulfamoiltiofenamid-származékok és gyógyszerként történõ alkalmazásuk hepatitis B kezelésére
EP2987678A4 (en) CHILD RESTRAINT DEVICE
HUE054161T2 (hu) Megnövelt stabilitású és javított abszorpciójú honokiol és magnolol készítmények és ezek alkalmazása
PL2769876T3 (pl) Fotelik samochodowy dla dzieci
ES1094985Y (es) Mini-moto infantil
TH1601002623A (th) การใช้เวย์ชนิดหวานดัดแปลงและเวย์ชนิดหวานดัดแปลงที่มีสูตรสำหรับทารกสำหรับ ส่งเสริมการพัฒนาระบบประสาทส่วนกลางของทารกและการทำงานของกระบวนการ รู้คิดที่เกี่ยวข้องภายหลังคลอด
CN302071116S (zh) 婴儿标签
Anton et al. Briefing on the Report" Healthy Development Summit II: Changing Frames and Expanding Partnerships to Promote Children's Mental Health and Social/Emotional Wellbeing"
CN302151667S (zh) 口服液瓶
CN302424016S (zh) 教学用纺车模型
CN302469698S (zh) 儿童座便器
ES1090460Y (es) Pieza para contruccion de estructuras y parques infantiles.
CN302227778S (zh) 自行车用幼儿座椅
CN302450305S (zh) 儿童组合书柜(ⅰ型)
CN302140619S (zh) 婴儿床护栏
CN302364263S (zh) 二氧化碳吸收装置
BR302013002175S1 (pt) "configuração aplicada em brinquedo infantil"
UA27940S (uk) Санки дитячі
TH48252S1 (th) ผ้าอ้อมสำเร็จรูปชนิดใช้แล้วทิ้ง
TH48251S1 (th) ผ้าอ้อมสำเร็จรูปชนิดใช้แล้วทิ้ง
TH140788S (th) ผ้าอ้อมสำเร็จรูปชนิดใช้แล้วทิ้ง
TH140787S (th) ผ้าอ้อมสำเร็จรูปชนิดใช้แล้วทิ้ง
CN302450051S (zh) 儿童可调节桌(ⅱ型)